L-citrulline/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“L-citrulline significantly improved FMD (L-citrulline 4.66 ± 0.45%; placebo 3.46 ± 0.37%, p = .045) at week 12 in participants with high-normal blood pressure at baseline.”
Quoted verbatim from Vascular effects of l-citrulline supplementation in healthy adults are largely influenced by the prehypertensive range of blood pressure: A double-blind, randomized, placebo-controlled, parallel-group study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 3000 mg L-citrulline, 12 weeks
- Population
- adults with high-normal blood pressure at baseline (subgroup); 12-week supplementation
Vascular effects of l-citrulline supplementation in healthy adults are largely influenced by the prehypertensive range of blood pressure: A double-blind, randomized, placebo-controlled, parallel-group study.2026PMID:42142423Permalink
Keep reading
- Everything the graph holds on L-citrulline
- Every compound studied against Flow-mediated dilation
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2R81S0HFS2KTDSHEAEGMSEA